Leading Biomedical industry and Research-Based Groups Launch Coalition against AMR Resistance
Originally published on the Canadian Antimicrobial Innovation Coalition (CAIC) website. To mark World Antimicrobial Awareness Week,...
top of page
- Jun 8, 2018
Canadian Declaration on Antimicrobial Resistance: Addressing the Multiple Challenges of AMR
Public awareness is growing in Canada and around the world about the urgent need for concerted global action to counter the serious...
- Jan 16, 2017
Fedora Pharmaceuticals Receives Support from the Government of Canada to Battle AMR
EDMONTON, Alberta – Fedora Pharmaceuticals, Inc. announced they have received nonrefundable financial contribution from the National...
- Feb 10, 2016
Super drugs for superbugs: Edmonton firm wins largest biotech licensing deal in Canadian history
Originally published on the National Research Council of Canada. EDMONTON, Alberta - Doctors around the world are starting to speak with...
- Jan 5, 2016
Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating AMR
Originally published on the Review on Antimicrobial Resistance. Antimicrobials, and specifically antibiotics, play a crucial role in...
- Nov 30, 2015
Fedora Pharmaceuticals Receives Alberta Life Sciences "Company of the Year" Award
EDMONTON, Alberta - Fedora Pharmaceuticals Receives Alberta Life Sciences "Company of the Year" Award EDMONTON, Alberta – November 30,...
- Nov 9, 2015
Fedora Pharmaceuticals Inc. Receives 2015 ASTech Award for Outstanding Commercial Achievement
EDMONTON, Alberta – November 9, 2015 – Fedora Pharmaceuticals Inc., a biotechnology company headquartered in Edmonton, Alberta, Canada,...
- Jan 13, 2015
Roche, Meiji and Fedora join forces to tackle increasing bacterial resistance to antibiotics
Originally published on Roche.com BASEL, Switzerland - Roche (SIX: RO, ROG; OTCQX: RHHBY), Meiji Seika Pharma (Meiji) and Fedora...
- Sep 12, 2013
FPI-1465 Increases Activity of Certain Antibiotics against Drug-Resistant Bacteria
Findings Presented at Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) EDMONTON, Alberta – September 12, 2013 –...
- Oct 31, 2012
Fedora Pharmaceuticals Appoints Ronald Odynski and Dr. Leonard Post to Board of Directors
EDMONTON, Alberta – October 31, 2012 – Fedora Pharmaceuticals, Inc. today announced the creation of a Board of Directors and appointment...
- Sep 5, 2012
Fedora Pharmaceuticals Appoints Thomas R. Parr, Ph.D., Chief Scientific Officer
EDMONTON, Alberta – September 5, 2012 – Fedora Pharmaceuticals, Inc. today announced the appointment of Thomas Parr, Ph.D. to the newly...
bottom of page